CEO Lawrence V. Bruno highlighted that "Core continued to execute its strategic plan of technology investments targeted to both solve client problems and capitalize on Core's technical and geographic ...

Earnings call Core Laboratories reported Q4 2025 revenue of $138.3M, up 3% sequentially and 7% YoY, with strong international service demand offsetting US softness. EPS ex items was $0.21, flat YoY.

Core Laboratories NV (CLB) reported its financial results for the third quarter of 2025, revealing earnings that fell short of analysts’ forecasts. The company posted earnings per share (EPS) of $0.22 ...

Good day, and welcome to the Core Laboratories Q2 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Larry Bruno, ...

Ariel Investments, an investment management company, released its “Ariel Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund delivered a +3.22% return in ...

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago. These ...

HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory ...

Core Laboratories NV (CLB) reported its third-quarter earnings for 2025, revealing a significant miss in both earnings per share (EPS) and revenue compared to market forecasts. The company’s EPS came ...